333 related articles for article (PubMed ID: 34638400)
21. Vascular niches for disseminated tumour cells in bone.
Kusumbe AP
J Bone Oncol; 2016 Sep; 5(3):112-116. PubMed ID: 27761369
[TBL] [Abstract][Full Text] [Related]
22. Role of myeloid-derived suppressor cells in tumor recurrence.
Cole K; Al-Kadhimi Z; Talmadge JE
Cancer Metastasis Rev; 2023 Mar; 42(1):113-142. PubMed ID: 36640224
[TBL] [Abstract][Full Text] [Related]
23. Weaving the nest: extracellular matrix roles in pre-metastatic niche formation.
Patras L; Paul D; Matei IR
Front Oncol; 2023; 13():1163786. PubMed ID: 37350937
[TBL] [Abstract][Full Text] [Related]
24. Myeloid derived suppressor cells and the release of micro-metastases from dormancy.
Khadge S; Cole K; Talmadge JE
Clin Exp Metastasis; 2021 Jun; 38(3):279-293. PubMed ID: 34014424
[TBL] [Abstract][Full Text] [Related]
25. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
[TBL] [Abstract][Full Text] [Related]
26. Role of myeloid-derived suppressor cells in metastasis.
Cole K; Pravoverov K; Talmadge JE
Cancer Metastasis Rev; 2021 Jun; 40(2):391-411. PubMed ID: 33411082
[TBL] [Abstract][Full Text] [Related]
27. AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.
Axelrod HD; Valkenburg KC; Amend SR; Hicks JL; Parsana P; Torga G; DeMarzo AM; Pienta KJ
Mol Cancer Res; 2019 Feb; 17(2):356-369. PubMed ID: 30291220
[TBL] [Abstract][Full Text] [Related]
28. The metastatic niche and stromal progression.
Sleeman JP
Cancer Metastasis Rev; 2012 Dec; 31(3-4):429-40. PubMed ID: 22699312
[TBL] [Abstract][Full Text] [Related]
29. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.
Yadav AS; Pandey PR; Butti R; Radharani NNV; Roy S; Bhalara SR; Gorain M; Kundu GC; Kumar D
Front Oncol; 2018; 8():72. PubMed ID: 29616190
[TBL] [Abstract][Full Text] [Related]
30. Developing a dormancy-associated ECM signature in TNBC that is linked to immunosuppressive tumor microenvironment and selective sensitivity to MAPK inhibitors.
Dong Y; Bai J; Zhou J
Heliyon; 2024 Jun; 10(11):e32106. PubMed ID: 38868025
[TBL] [Abstract][Full Text] [Related]
31. Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.
Hen O; Barkan D
Semin Cancer Biol; 2020 Feb; 60():157-165. PubMed ID: 31491559
[TBL] [Abstract][Full Text] [Related]
32. The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.
Lam HM; Vessella RL; Morrissey C
Drug Discov Today Technol; 2014 Mar; 11():41-7. PubMed ID: 24847652
[TBL] [Abstract][Full Text] [Related]
33. The metastatic niche formation: focus on extracellular vesicle-mediated dialogue between lung cancer cells and the microenvironment.
Pontis F; Roz L; Fortunato O; Bertolini G
Front Oncol; 2023; 13():1116783. PubMed ID: 37207158
[TBL] [Abstract][Full Text] [Related]
34. Ecology and evolution of dormant metastasis.
Blasco MT; Espuny I; Gomis RR
Trends Cancer; 2022 Jul; 8(7):570-582. PubMed ID: 35370115
[TBL] [Abstract][Full Text] [Related]
35. Tumor Dormancy: Biologic and Therapeutic Implications.
Balayan V; Guddati AK
World J Oncol; 2022 Feb; 13(1):8-19. PubMed ID: 35317328
[TBL] [Abstract][Full Text] [Related]
36. Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells.
Borriello L; Coste A; Traub B; Sharma VP; Karagiannis GS; Lin Y; Wang Y; Ye X; Duran CL; Chen X; Friedman M; Sosa MS; Sun D; Dalla E; Singh DK; Oktay MH; Aguirre-Ghiso JA; Condeelis JS; Entenberg D
Nat Commun; 2022 Feb; 13(1):626. PubMed ID: 35110548
[TBL] [Abstract][Full Text] [Related]
37. Cancer Cell Dormancy in Metastasis.
Summers MA; McDonald MM; Croucher PI
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31548220
[TBL] [Abstract][Full Text] [Related]
38. Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy.
Bhatia R; Chang J; Munoz JL; Walker ND
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371709
[TBL] [Abstract][Full Text] [Related]
39. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
40. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
